Nucleic acid delivery for advanced therapies

Wednesday 14:00 BST / 15:00 CEST / 16:00 EEST / 16:00 EAT / 17:00 +04

Sponsor

Nucleic acid delivery for advanced therapies

Explore the latest breakthroughs in nucleic acid delivery with insights from experts at NIH, NeoVac, and Sartorius BIA Separations. This session focuses on scalable RNA manufacturing, advanced purification, and the rational design of LNPs for targeted delivery.

Join this session for expert insights into:

Achieving high RNA purity and yield with high-quality DNA templates and scalable purification workflows
Ensuring consistent, safe, and effective production of nucleic acid products through effective CMC processes
Applying innovative approaches to modulating gene expression for therapeutic applications
Creating LNPs and amino ionizable lipids with tailored immunogenic properties for repeated dosing and targeted delivery

Timings:

Event Introduction, Roisin McGuigan (0.00-02:00)
Optimizing mRNA Manufacturing: High Purity and Yield, Enhancing mRNA Production with Advanced Purification, Rok Sekernik (~02:00-47:00)
RNA Delivery and Gene Expression Modulation Innovations, Innovations in RNA Delivery and Gene Expression, Dan Peer (~47:00-01:33:00)

Rok Sekirnik

Head Process Development for mRNA and pDNA at Sartorius BIA Separations

Rok Sekirnik completed his PhD at Oxford University. He has worked in the areas of mAb, vaccine, and gene therapy vector development. His team at Sartorius BIA Separations is focused on developing high-yielding, cost-effective purification approaches for pDNA and mRNA production.

Dan Peer

Professor and Director of the Laboratory, Precision NanoMedicine

Dan Peer, PhD, is the chairman of NeoVac as well as a professor and the director of the Laboratory of Precision NanoMedicine at Tel Aviv University. His lab was the first to show systemic, high efficiency, cell specific, therapeutic genome editing in cancer.

You have registered for this webinar